GlassScriptPhysician profile
Aakash Thakral
NPI 1831544816
$14,154.17
in general payments reported to CMS, 2019-2025
22 companies · $2,274 in 2025
The $2,274 reported for 2025 was more than what 94% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $127 · 2021: $173 · 2022: $1,741 · 2023: $6,013 · 2024: $3,826 · 2025: $2,274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Travel and Lodging: $2,043.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,069.82 |
| Travel and Lodging | $2,043.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $6,046.84 | 2021-2025 | Wavewriter Alpha Prime 16, General - Pain Management, General - Therapies |
| Medtronic, INC. | $2,714.68 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Abbott Laboratories | $1,566.09 | 2022-2025 | Proclaim, Eterna |
| Nalu Medical, INC. | $1,090.22 | 2022-2024 | Nalu Neurostimulation System |
| Mml US, INC. | $640.64 | 2023-2025 | Reactiv8 |
| Nevro Corp. | $603.30 | 2023-2024 | Senza |
| Stryker Corporation | $420.01 | 2023-2025 | Mild Device Kit, Spinejack, Optablate |
| Biotronik Nro, INC. | $234.27 | 2025 | Prospera |
| Spr Therapeutics, INC | $221.42 | 2021-2025 | Sprint Pns System |
| Relievant Medsystems, INC. | $213.76 | 2023 | Intracept |
| Allergan, INC. | $126.54 | 2019 | |
| Bioventus LLC | $70.50 | 2022 | |
| Abbvie INC. | $55.17 | 2023 | Botox, Ubrelvy |
| Avanos Medical | $21.28 | 2023 | Coolief* Cooled Radiofrequency |
| Vertex Pharmaceuticals Incorporated | $19.04 | 2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $17.86 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $17.70 | 2023 | Exparel, Iovera, Zilretta |
| Synergy Orthopedics, LLC | $17.32 | 2023 | |
| Collegium Pharmaceutical, INC. | $16.93 | 2025 | Xtampza |
| Sanofi-Aventis U.S. LLC | $14.84 | 2021 | |
| Tactile Systems Technology INC | $14.17 | 2024 | Entre Plus, Flexitouch Plus |
| Saluda Medical Americas, INC. | $11.59 | 2023 | Evoke Scs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aakash Thakral listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.